US Patent Issued to Exuma Biotech on March 25 for "Methods and compositions for transducing lymphocytes and regulating the activity thereof" (American, Null Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,574, issued on March 25, was assigned to Exuma Biotech Corp. (West Palm Beach, Fla.).

"Methods and compositions for transducing lymphocytes and regulating the activity thereof" was invented by Gregory Ian Frost (West Palm Beach, Fla.), James Joseph Onuffer Jr. (Alameda, Calif.), Ghiabe H. Guibinga (San Diego), Farzad Haerizadeh (San Diego) and Anirban Kundu (Grand Cayman, Cayman Islands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for genetically modifying lymphocytes and methods for performing adoptive cellular therapy that include transducing T cells and/or NK cells. The methods can include inhibitory RNA...